Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Novo Nordisk(NVO) CNBC·2025-03-28 21:37Novo Nordisk(NVO) CNBC·2025-03-28 21:37
R1Novo Nordisk(NVO) CNBC·2025-03-28 21:37 R1Novo Nordisk(NVO) CNBC·2025-03-28 21:37